Puma Biotechnology, Inc. (PBYI)

10.29 +0.32 (+3.21%) USD  |  NASDAQ  |  Oct 09, 16:00
10.29 0.00 (0.00%) After-Hours: 16:50
More

Puma Biotechnology Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for PBYI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 06, 2026 --
May 08, 2026 --
February 27, 2026 --
February 20, 2026 --
November 07, 2025 --
August 08, 2025 --
May 16, 2025 --
Date Value
May 09, 2025 --
February 28, 2025 --
February 21, 2025 --
November 08, 2024 --
August 02, 2024 --
July 26, 2024 --
May 03, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Arcutis Biotherapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
Vericel Corp. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade